In summary, IUGR continued to disrupt colonic barrier function by inhibiting antioxidant capacity via the Nrf2/Keap1 pathway and activating inflammation via the TLR4-NF-κB/ERK pathway in growing-finishing pigs. The gene discussed is KEAP1; the disease is fetal growth restriction.